Understanding on CRISPR/Cas9 mediated cutting-edge approaches for cancer therapeutics
Crossref DOI link: https://doi.org/10.1007/s12672-022-00509-x
Published Online: 2022-06-08
Published Print: 2022-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bhattacharjee, Rudrarup
Das Roy, Lopamudra
Choudhury, Amarendranath
Text and Data Mining valid from 2022-06-08
Version of Record valid from 2022-06-08
Article History
Received: 31 March 2022
Accepted: 1 June 2022
First Online: 8 June 2022
Declarations
:
: The authors declare no competing interests.